dacarbazine and bay 60-6583

dacarbazine has been researched along with bay 60-6583 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Iannone, R; Maiolino, P; Miele, L; Morello, S; Pinto, A	1

Other Studies

1 other study(ies) available for dacarbazine and bay 60-6583

Article	Year
Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma. Neoplasia (New York, N.Y.), 2013, Volume: 15, Issue:12 Topics: Adenosine A2 Receptor Antagonists; Aminopyridines; Animals; Antineoplastic Agents; Cell Line, Tumor; Chemokine CCL2; Dacarbazine; Drug Screening Assays, Antitumor; Drug Synergism; Female; Immunosuppressive Agents; Interleukin-10; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Myeloid Cells; Natural Killer T-Cells; Neoplasm Transplantation; Receptor, Adenosine A2B; Tumor Burden; Tumor Escape; Tumor Microenvironment; Xanthines	2013

Article

Year

Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma.

Neoplasia (New York, N.Y.), 2013, Volume: 15, Issue:12

Topics: Adenosine A2 Receptor Antagonists; Aminopyridines; Animals; Antineoplastic Agents; Cell Line, Tumor; Chemokine CCL2; Dacarbazine; Drug Screening Assays, Antitumor; Drug Synergism; Female; Immunosuppressive Agents; Interleukin-10; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Myeloid Cells; Natural Killer T-Cells; Neoplasm Transplantation; Receptor, Adenosine A2B; Tumor Burden; Tumor Escape; Tumor Microenvironment; Xanthines

2013